EBER1 in situ hybridization as an adjuvant for diagnosis of recurrent nasopharyngeal carcinoma

Anticancer Research

Volumn 18, Issue 6 B, 1998, Pages 4585-4590

  Hsiao, Jenn Ren ^a   Jin, Yin Tai ^a   Tsai, Sen Tien ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

EBER1 in situ hybridization; Irradiation; Nasopharyngeal carcinoma (NPC); Recurrence

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CELL NUCLEUS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CYTOPLASM; DIAGNOSTIC ERROR; FIBROSIS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFLAMMATION; NASOPHARYNX CARCINOMA; NECROSIS; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY;

CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; FIBROSIS; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NECROSIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RNA, VIRAL; STROMAL CELLS;

EID: 0032437721     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hsu MM, Tu SM: Nasopharyngeal carcinoma in Taiwan: clinical manifestations and results of therapy. Cancer 52: 362-368, 1983.
2. Chong VFH, Fan Y-F: Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 202: 463-470, 1997.
3. Bibbo M. Comprehensive cytology. W.B.Saunders, Philadelphia, 1991, pp 860-863.
4. Tsai ST, Jin YT, Su IJ: Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissue using in situ hybridization: a correlation with WHO histological subtypes. Cancer 77: 231-236, 1996.
5. Tsai ST, Jin YT, Mann RB, Ambinder RF: Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer 82: 1449-1453, 1998.
6. Pathmanathan R, Prasad U, Saldler R, Flynn K, Raab-Traub N: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333: 693-698, 1995.
7. Sam CK, Brooks LA, Niedobitek G, Young LS, Prasad U, Rickson AB: Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk area of nasopharyngeal carcinoma. Int J Cancer 53: 957-962, 1993.
8. Hsu MM, Ko JY, Sheen TS, Chang YL: Salvage surgery for recurrent nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 123: 305-309, 1997.
9. Tsai ST, Jin YT, Wu TC: Synthesis of PCR-derived digoxiginin-labelled DNA probes for in situ detection of EBERs in Epstein-Barr virus-infected cells. J Virol Methods 54: 67-74, 1995.
10. Wei WI, Ho CM, Yuen PW, Fung CF, Sham JST, Lam KH: Maxillary swing approach for resection of tumors in and around the nasopharynx. Arch Otolaryngol Head Neck Surg 121: 638-642, 1995.
11. Wang CC: Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int J Radiat Oncol Biol Phys 13: 953-936, 1987.
12. Sham JST, Choy D, Wei WI, Yau CC: Value of clinical follow-up for local nasopharyngeal carcinoma relapse. Head Neck 14: 208-217, 1992.
13. Nicholls J, Sham J, Ng MH, Choy D: In-situ carcinoma adjacent to recurrent nasopharyngeal carcinoma: evidence of a new growth? Path Res Pract 189: 1067-1070, 1993.
14. Brown JJ, Berry GJ, Moretto J, Keating WF, Fee WE Jr: Validity of clinical biopsy specimens in classifying histopathologic characteristics of recurrent nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 23: 950-955, 1997.
15. Chen CL, Hsu MM, Hsu HC: Differential expression of EBER1 in nontumor nasopharyngeal biopsieo and nontumor component of nasopharyngeal carcinoma. Intervirology 39: 230-235, 1996.
16. Yeung WM, Zong YS, Chiu CT, Chan KH, Sham JST, Choy DTK, Ng MH: Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 53: 746-750, 1993.
17. Sixbey JW, Yao QY: Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255: 1578-1580, 1992.